Suchergebnisse - "Janetka, James W"

PubPharm (8)

1

Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2018

von Kalas, V. | Hibbing, M. | Maddirala, A. | +6

2

Rational design strategies for FimH antagonists : new drugs on the horizon for urinary tract infection and Crohn's disease

enthalten in: Expert opinion on drug discovery | 2017

von Mydock-McGrane, L. | Hannan, T. | Janetka, J.

3

Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections

enthalten in: Journal of medicinal chemistry | 2016

von Mydock-McGrane, L. | Cusumano, Z. | Han, Z. | +10

4

Antivirulence Isoquinolone Mannosides : Optimization of the Biaryl Aglycone for FimH Lectin Binding Affinity and Efficacy in the Treatment of Chronic UTI

enthalten in: ChemMedChem | 2016

von Jarvis, C. | Han, Z. | Kalas, V. | +9

5

Mannose-derived FimH antagonists : a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease

enthalten in: Expert opinion on therapeutic patents | 2016

von Mydock-McGrane, L. | Cusumano, Z. | Janetka, J.

6

A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131

enthalten in: The Journal of infectious diseases | 2013

von Totsika, M. | Kostakioti, M. | Hannan, T. | +5

CommentIn: J Urol. 2014 Jul;192(1):276. - PMID 25629130

7

Treatment and prevention of urinary tract infection with orally active FimH inhibitors

enthalten in: Science translational medicine | 2011

von Cusumano, C. | Pinkner, J. | Han, Z. | +6

CommentIn: Nat Rev Urol. 2012 Jan;9(1):6. - PMID 22200833

8

Structure-based drug design and optimization of mannoside bacterial FimH antagonists

enthalten in: Journal of medicinal chemistry | 2010

von Han, Z. | Pinkner, J. | Ford, B. | +8

1
[1]